ClearBridge Investments
AXSM icon

ClearBridge Investments’s Axsome Therapeutics AXSM Stock Holding History

ClearBridge Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.1M Buy
245,574
+200,554
+445% +$43.5M 0.05% 307
2026
Q1 		$7.61M Sell
45,020
-1,306
-3% -$226K 0.01% 499
2025
Q4 		$8.46M Sell
46,326
-11,341
-20% -$1.58M 0.01% 513
2025
Q3 		$7M Buy
57,667
+1,351
+2% +$152K 0.01% 557
2025
Q2 		$5.88M Sell
56,316
-11,848
-17% -$1.25M ﹤0.01% 556
2025
Q1 		$7.95M Sell
68,164
-44,913
-40% -$5.12M 0.01% 527
2024
Q4 		$9.57M Sell
113,077
-1,159
-1% -$107K 0.01% 538
2024
Q3 		$10.3M Buy
114,236
+7,469
+7% +$652K 0.01% 524
2024
Q2 		$8.59M Buy
106,767
+17,397
+19% +$1.29M 0.01% 553
2024
Q1 		$7.13M Buy
+89,370
New +$7.5M 0.01% 566

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ClearBridge Investments's AXSM Position: Q2 2026 in Review

ClearBridge Investments increased its Axsome Therapeutics (AXSM) stake by 445% in Q2 2026, buying an estimated $43.5M and bringing the position to 245,574 shares worth $60.1M. The position accounts for 0.05% of the portfolio, ranked #307.

ClearBridge Investments first reported a position in AXSM in Q1 2024 and has held it in 10 quarters since. 504 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • ClearBridge Investments held 245,574 shares of Axsome Therapeutics worth $60.1M as of Q2 2026.
  • ClearBridge Investments bought 200,554 Axsome Therapeutics shares in Q2 2026, an estimated $43.5M.
  • Axsome Therapeutics made up 0.05% of ClearBridge Investments's portfolio in Q2 2026, its #307 holding.
  • ClearBridge Investments first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 504 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.